mTOR Inhibition and Trastuzumab-Emtansine (T-DM1) in HER2-Positive Breast Cancer

0
49
Everolimus in combination with T-DM1 showed strong antitumor effects in HER2-positive breast cancer, both in vitro and in vivo.
[Molecular Cancer Research]
Abstract